On 29 January, Vericel Corporation (NASDAQ:VCEL), announced the completion of patient enrollment in the company’s Phase 2b ixCELL-DCM clinical trial evaluating ixmyelocel-T for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM). Top-line results from this study are expected around the end of the first quarter of 2016. On Friday shares of Vericel Corporation (NASDAQ:VCEL) closed at $3.48.
CBOE Holdings Inc. (NASDAQ:CBOE) reported downbeat earnings for the fourth quarter. The Chicago, Illinois-based company posted quarterly net income of $49.3 million, or $0.58 per share, compared to $45.6 million, or $0.52 per share, in the year-ago quarter. Its adjusted earnings came in at $0.64 per share. CBOE Holdings, Inc. (NASDAQ:CBOE) in last trading activity decreased -4.12% to close at $62.46. Company weekly performance is -3.13% while its quarterly performance stands at 1.95%. CBOE Holdings, Inc. (NASDAQ:CBOE) is -8.15% away from its 52 week high.
IntriCon Corporation (NASDAQ:IIN) announced that it will release its 2014 fourth-quarter results on Tuesday, February 17, 2015, at 3:00 p.m. CT. On last trading day Intricon Corp. (NASDAQ:IIN) increased 0.69% to close at $7.29. Its volatility for the week is 4.53% while volatility for the month is 4.57%. IIN’s sales growth for past 5 years was -1.80% and its EPS growth for past 5 years was -29.70%. Intricon Corp. (NASDAQ:IIN) monthly performance is -5.32%.
Canaccord Genuity reissued their sell rating on shares of British American Tobacco plc (NYSEMKT:BTI) in a research note released on Friday morning. They currently have a ($44.12) target price on the stock. British American Tobacco plc (NYSEMKT:BTI) institutional ownership stands at 3.50%. In last trading activity company’s stock closed at $110.89.
Harris Corporation (NYSE: HRS) and Exelis, Inc. announced a definitive agreement under which Harris will acquire Exelis in a cash and stock transaction valued at $23.75 per share, or an approximately $4.75 billion enterprise value. The agreement has been unanimously approved by the Boards of Directors of both companies. The transaction is expected to close in June 2015 and is subject to customary closing conditions, including regulatory and Exelis shareholder approval. On last trading day Harris Corporation (NYSE:HRS) moved up 9.63% to close at $76.18. Its volatility for the week is 2.64% while volatility for the month is 2.04%. HRS’s EPS growth for past 5 years was 16.50%. Harris Corporation (NYSE:HRS) monthly performance is 11.26%.